Thursday, July 6, 2017
INC Research Holdings, Inc., a leading, global phase I to IV contract research organization, has announced the launch of the Company’s Psychiatry Catalyst Site Network as part of its Catalyst program introduced in 2016 to strengthen collaborations with clinical research sites worldwide. The ultimate goal of the program is to enhance patient focus and optimize study delivery to drive improved predictability and increased efficiency for customers. INC selected 32 high-performing clinical research sites to participate in the initial launch of the Psychiatry Catalyst Site Network, which was formed to respond to the rapid growth and strong pipeline of psychiatric studies. The Psychiatry Catalyst Site Network joins INC’s existing networks in place in support of Oncology and Vaccine clinical research.